Brief: Kolinpharma Obtains Patent For Doltendix In Italy
27/01/2022 06:27
Jan 27 (Reuters) - Kolinpharma Spa KIP.MI :
* OBTAINS PATENT FOR DOLTENDIX IN ITALY
* VALIDITY OF PATENT UNTIL DEC 2039
Further company coverage: KIP.MI
(Reporting by Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Kolinpharma SpA
See all newsBrief: Igea Holding Crosses 95% Of Kolinpharma In Context Of Takeover Bid
Brief: Kolinpharma Shareholder PRP Sells About 59.62% Of Share Capital To Igea Holding
Brief: Igea Holding Buys Additional 0.927% Of Kolinpharma Share Capital
Brief: Takeup In Takeover Bid By Igea Holding On Kolinpharma Reaches 59.411% Of Shares To Which Offer Relates
Brief: Igea Holding Buys 4.9% Of Kolinpharma Share Capital, Surpasses 90% Treshold